Medicus Pharma Ltd. (NASDAQ: MDCX) has submitted a federal priority-review request for its investigational SkinJect microneedle patch, a dissolvable doxorubicin-based therapy designed to ...
Morning Overview on MSN
Nasal drops show promise against a common deadly brain cancer
For one of the most lethal brain cancers known, a simple nasal drop is emerging as an unexpectedly sophisticated weapon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback